Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 08 2023
Historique:
received: 10 04 2023
accepted: 07 08 2023
medline: 28 8 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: epublish

Résumé

Hydroxysteroid 17-beta-dehydrogenase 13 (HSD17B13) is a hepatic lipid droplet-associated enzyme that is upregulated in patients with non-alcoholic fatty liver disease. Recently, there have been several reports that predicted loss of function variants in HSD17B13 protect against the progression of steatosis to non-alcoholic steatohepatitis with fibrosis and hepatocellular carcinoma. Here we report crystal structures of full length HSD17B13 in complex with its NAD

Identifiants

pubmed: 37620305
doi: 10.1038/s41467-023-40766-0
pii: 10.1038/s41467-023-40766-0
pmc: PMC10449848
doi:

Substances chimiques

Lipid Droplet Associated Proteins 0
Lipids 0
HSD17B13 protein, human EC 1.1.-.-
17-Hydroxysteroid Dehydrogenases EC 1.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5158

Informations de copyright

© 2023. Springer Nature Limited.

Références

J Hepatol. 2020 Sep;73(3):505-515
pubmed: 32298765
Am J Physiol Gastrointest Liver Physiol. 2018 Jan 1;314(1):G97-G108
pubmed: 29025729
J Med Chem. 2023 Feb 23;66(4):2832-2850
pubmed: 36727857
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
J Steroid Biochem Mol Biol. 2011 May;125(1-2):66-82
pubmed: 21193039
Biochem Biophys Res Commun. 2008 May 30;370(2):235-8
pubmed: 18359291
J Endocrinol. 2007 Aug;194(2):449-55
pubmed: 17641292
Biochim Biophys Acta. 2004 Feb 2;1644(1):47-59
pubmed: 14741744
J Biol Chem. 2005 Feb 4;280(5):3789-94
pubmed: 15542590
Anal Biochem. 2004 Sep 1;332(1):153-9
pubmed: 15301960
Curr Opin Drug Discov Devel. 2010 Jul;13(4):389-402
pubmed: 20597025
Mol Cell Endocrinol. 2011 Aug 22;343(1-2):1-6
pubmed: 21708223
PLoS One. 2013 May 23;8(5):e63594
pubmed: 23717450
Biochem J. 1996 Mar 15;314 ( Pt 3):839-45
pubmed: 8615778
Chem Biol Interact. 2015 Jun 5;234:105-13
pubmed: 25619643
Toxicol Appl Pharmacol. 2021 Feb 1;412:115387
pubmed: 33387577
Arch Biochem Biophys. 1975 Jun;168(2):436-42
pubmed: 237481
N Engl J Med. 2018 Mar 22;378(12):1096-1106
pubmed: 29562163
Biochem J. 1969 Dec;115(4):609-19
pubmed: 4391039
J Biol Chem. 2018 May 4;293(18):6996-7007
pubmed: 29567832
Nat Commun. 2022 Nov 2;13(1):6577
pubmed: 36323699
J Biol Chem. 2004 Apr 16;279(16):16778-85
pubmed: 14966133
J Biol Chem. 2002 Aug 30;277(35):32253-7
pubmed: 12077142
Biochim Biophys Acta. 2012 Jan;1821(1):124-36
pubmed: 21763780
J Biol Chem. 1999 May 14;274(20):14122-9
pubmed: 10318829
Mol Cell Endocrinol. 2004 Apr 15;218(1-2):7-20
pubmed: 15130507
Acta Biochim Pol. 2007;54(1):213-8
pubmed: 17311113
Dev Cell. 2018 Jan 8;44(1):97-112.e7
pubmed: 29275994
Nat Rev Mol Cell Biol. 2019 Mar;20(3):137-155
pubmed: 30523332
FASEB J. 2018 Jun;32(6):3434-3447
pubmed: 29401633
Cancers (Basel). 2021 Aug 31;13(17):
pubmed: 34503201
Hepatology. 2021 May;73(5):1701-1716
pubmed: 32779242
Mol Cell Endocrinol. 2019 Jun 1;489:32-44
pubmed: 30408503
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4083-8
pubmed: 15016920
Endocr Rev. 1997 Jun;18(3):281-305
pubmed: 9183566
J Biol Chem. 2015 Oct 30;290(44):26361-72
pubmed: 26350461
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
J Mol Endocrinol. 2005 Aug;35(1):89-101
pubmed: 16087724
Hepatology. 2019 Apr;69(4):1504-1519
pubmed: 30415504
Curr Opin Cell Biol. 2014 Aug;29:39-45
pubmed: 24736091
Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):479-88
pubmed: 17515892
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Annu Rev Biochem. 2012;81:687-714
pubmed: 22524315
Biochemistry. 2010 Dec 28;49(51):10831-41
pubmed: 21050007
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2210-21
pubmed: 15572774
Arch Biochem Biophys. 2008 Nov 15;479(2):121-30
pubmed: 18804447
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):293-302
pubmed: 21460447
Nat Rev Genet. 2013 Dec;14(12):880-93
pubmed: 24217315
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90
pubmed: 24042449
J Biomol Screen. 2010 Mar;15(3):314-20
pubmed: 20150591
Aliment Pharmacol Ther. 2023 Jan;57(1):37-51
pubmed: 36349732
J Biol Chem. 2006 May 19;281(20):14232-40
pubmed: 16571721
Mol Cells. 2021 Apr 30;44(4):214-222
pubmed: 33935042
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11437-42
pubmed: 25028495
Methods Enzymol. 2021;656:545-571
pubmed: 34325798
J Biol Chem. 2002 Nov 15;277(46):44507-12
pubmed: 12221100
J Lipid Res. 2020 Nov;61(11):1400-1409
pubmed: 32973038
Mol Endocrinol. 2001 Nov;15(11):2010-20
pubmed: 11682630
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
N Engl J Med. 2018 Nov 8;379(19):1876-1877
pubmed: 30403941
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350

Auteurs

Shenping Liu (S)

Medicine Design, Pfizer Inc, Groton, CT, 06340, USA. Shenping.Liu@pfizer.com.

Ruth F Sommese (RF)

Medicine Design, Pfizer Inc, Groton, CT, 06340, USA. Ruth.Sommese@pfizer.com.

Nicole L Nedoma (NL)

Medicine Design, Pfizer Inc, Groton, CT, 06340, USA.

Lucy Mae Stevens (LM)

Medicine Design, Pfizer Inc, Groton, CT, 06340, USA.

Jason K Dutra (JK)

Medicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.

Liying Zhang (L)

Medicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.
Discovery Chemistry, Merck Research Laboratories, Cambridge, MA, USA.

David J Edmonds (DJ)

Medicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.
Medicinal Chemistry, Roche, Basel, Switzerland.

Yang Wang (Y)

Medicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.

Michelle Garnsey (M)

Medicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.

Michelle F Clasquin (MF)

Internal Medicine Research Unit, Pfizer Inc, Cambridge, MA, 02139, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH